Search Results - David Allsup
-
1
Fixed Duration Ibrutinib‐Venetoclax, a Redefinition of the CLL Treatment Landscape
Published 2025Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
2
Pirtobrutinib at the Crossroads: Shaping Its Future Role in Chronic Lymphocytic Leukemia ( CLL ) Care
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
3
Network meta‐analysis of upfront fixed‐duration therapies in chronic lymphocytic leukemia
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
4
Prevalence of BTK and PLCG2 Mutations in CLL Patients With Disease Progression on BTK Inhibitor Therapy: A Meta‐Analysis
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
5
Cardiovascular Safety Across Leading BTK Inhibitors in Relapsed/Refractory CLL : Results of a Network Meta‐Analysis
Published 2026Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso -
6
High‐Risk Chronic Lymphocytic Leukemia Complicating the Course of Imatinib‐Treated Chronic Myeloid Leukemia: Successful Disease Management With Dual Tyrosine Kinase Inhibition
Published 2024Fuente: Wiley Open AccessTipo de material: Artículo Open AccessAcceso al recurso